Vaping is especially popular among teenagers and young adults, but fruity, candy-like flavours come with a chemical cost ...

Belrestotug plus dostarlimab showed no progression-free survival benefit in NSCLC, leading GSK and iTeos to discontinue all ...

Diacetyl, or 2,3-butanedione, is a flavoring agent that becomes a toxic inhalant when aerosolized. It causes inflammation and ...

Revolution Medicines has dosed the first subject in the Phase III RASolve 301 trial with the RAS (ON) multi-selective ...

A recent study reports that disruption of tracheal basal cell homeostasis is the key cellular event driving lung squamous ...

AbbVie has claimed its first regulatory approval, from the FDA, for its C-met-targeting antibody-drug conjugate (ADC) Emrelis ...

Amplia Therapeutics and Immutep have released clinical trial results that promise more effective treatments for pancreatic and lung cancers ...

Exelixis delivers a strong Q1 performance with raised 2025 guidance, robust Cabometyx sales, and share buybacks. Read the ...

Ideaya Biosciences, Inc. progresses trials for uveal melanoma and solid tumors, with key upcoming data milestones. Click for ...

LNG contracts last for 20 or 30 years and much like buying a house, buying LNG is a multi-step process. In real estate, you ...

The U.S. FDA granted Abbvie Inc. accelerated approval for antibody-drug conjugate (ADC) Teliso-V (telisotuzumab vedotin), newly branded Emrelis, making it the first treatment for previously treated ...

Released in time for Mother's Day, the Colombian American pop star's latest album, 'Sincerely,' is her most unguarded and ...